Evidence map›Paper›PMID 33277506›Full record

ArticleNature communications2020

Structure and dynamics of an α-fucosidase reveal a mechanism for highly efficient IgG transfucosylation.

Erik H Klontz, Chao Li, Kyle Kihn, James K Fields, Dorothy Beckett, Greg A Snyder, Patrick L Wintrode, Daniel Deredge, Lai-Xi Wang, Eric J Sundberg

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Structural insights into a fucosidase involved in fucoidan degradation.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  8. Article
  9. A Robust α-l-Fucosidase fromACS chemical biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Erik H KlontzInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Chao LiDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, 20742, USA.ORCID 0000-0002-8090-2017
Kyle KihnDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, College Park, MD, 21201, USA.
James K FieldsInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Dorothy BeckettDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, 20742, USA.ORCID 0000-0002-7838-0651
Greg A SnyderInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.ORCID 0000-0002-4409-0453
Patrick L WintrodeDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, College Park, MD, 21201, USA.
Daniel DeredgeDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, College Park, MD, 21201, USA.
Lai-Xi WangDepartment of Chemistry and Biochemistry, University of Maryland, College Park, MD, 20742, USA.
Eric J SundbergInstitute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. eric.sundberg@emory.edu.ORCID 0000-0003-0478-3033
University of Maryland, College Park · USUniversity of Maryland, Baltimore · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Covergent Chemoenzymatic Synthesis of Glycopeptides and GlycoproteinsR01GM080374 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI WANG, LAI-XI · 2007 to 2021
$3.9M
Technologies to predict and probe glycosyl transferR01GM127578 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GRAY, JEFFREY J · 2018 to 2020
$1.6M
Towards one-step enzymatic defucosylation of antibodiesR21AI154232 · NIAID · EMORY UNIVERSITY · PI SUNDBERG, ERIC JOHN · 2020 to 2021
$429k
NIAID NIH HHS R21 AI154232NIAID NIH HHS T32 AI095190NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM080374NIGMS NIH HHS R01 GM127578
6 · The paper itself

Abstract

Fucosylation is important for the function of many proteins with biotechnical and medical applications. Alpha-fucosidases comprise a large enzyme family that recognizes fucosylated substrates with diverse α-linkages on these proteins. Lactobacillus casei produces an α-fucosidase, called AlfC, with specificity towards α(1,6)-fucose, the only linkage found in human N-glycan core fucosylation. AlfC and certain point mutants thereof have been used to add and remove fucose from monoclonal antibody N-glycans, with significant impacts on their effector functions. Despite the potential uses for AlfC, little is known about its mechanism. Here, we present crystal structures of AlfC, combined with mutational and kinetic analyses, hydrogen-deuterium exchange mass spectrometry, molecular dynamic simulations, and transfucosylation experiments to define the molecular mechanisms of the activities of AlfC and its transfucosidase mutants. Our results indicate that AlfC creates an aromatic subsite adjacent to the active site that specifically accommodates GlcNAc in α(1,6)-linkages, suggest that enzymatic activity is controlled by distinct open and closed conformations of an active-site loop, with certain mutations shifting the equilibrium towards open conformations to promote transfucosylation over hydrolysis, and provide a potentially generalizable framework for the rational creation of AlfC transfucosidase mutants.

Indexed as

Molecular Dynamics SimulationProtein Conformationalpha-L-FucosidaseBacterial ProteinsCatalytic DomainFucoseGlycosylationHumansImmunoglobulin GKineticsLacticaseibacillus caseiMutationPolysaccharidesSubstrate Specificityalpha-L-FucosidaseBacterial ProteinsFucoseImmunoglobulin GPolysaccharides

Identifiers

PMID33277506
PMCPMC7718225
OpenAlexW3108864910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.